fbpx

Day

december 11, 2015
Veloxis Pharmaceuticals A/S (NASDAQ: VELO) announced today that Dr. William J. Polvino steps down as President and CEO after more than six years in the role.
93% of patients had full or partial cyst resolution at 12 months. No post-operative infections reported during follow-up period. No fractures reported during the follow-up period

Nyheder

Lundbeckfonden
Hjernesygdomme koster samfundet mindst 39 mia. kroner
18. november 2020
Danske forskere leverer beviset: Kejsersnit kan lede til astma og allergi
12. november 2020
En helt ny slags ’antabus’ – men mod kokainmisbrug
10. november 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge